Testing effectiveness (Phase 2)Study completedNCT00748358
What this trial is testing
An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer
Who this might be right for
Prostatic NeoplasmsNeoplasms, Hormone-DependentTumor Markers, Biological+2 more
Assistance Publique - Hôpitaux de Paris 50